Hardcore Energize Bullet, New Whey Liquid Products Recalled for TamperingJul 6, 2009 | Parker Waichman LLP
Consumers are being warned not to use or purchase either Hardcore Energize Bullet or New Whey Liquid Products, which have been recalled due to suspected tampering, said the U.S. Food and Drug Administration (FDA).
The FDA explained that Hardcore Energize Bullet and New Whey liquid products are sold in test tube-like vials.
The suspected tampering involved a utility knife blade found in one vial of Hardcore Energize Bullet drink, manufactured in the United States and sold in Canada, and another blade in one vial of New Whey liquid products, manufactured and sold in the United States. To date, there have been no reports of injuries.
Protica Inc., of Whitehall, Pennsylvania, manufactures both the Hardcore Energize Bullet and the New Whey liquid products. Protica is investigating the alleged tampering incident.
Hardcore Energize Bullet liquid products were distributed in Canada and are being recalled by iSatori Technologies of Golden, Colorado. The Hardcore Energize Bullet liquid is packaged in 2.9 ounce clear, test-tube like vials and come in two flavors: Blue Rage and Black Rush. The affected lots for the Blue Rage liquid product are: 1961, 1962, and 1794. The affected lot for the Black Rush liquid product is 1963.
New Whey liquid products were distributed and are being recalled by IDS of Oviedo, Florida and were sold at various retail stores. The New Whey liquid is packaged in 2.9 ounce clear, test-tube like vials and comes in two flavors: New Whey Fruit Punch 25g and New Whey Blue Raspberry 42g. The affected lot for the New Whey Fruit Punch liquid product is 1960. The affected lot for the New Whey Blue Raspberry liquid product is 1944.
The FDA is urging consumers who may have purchased these products not to consume them. Health care professionals and consumers are encouraged to report serious adverse effects or product quality problems with the use of Hardcore Energize Bullet and New Whey liquid products to the FDA's MedWatch Adverse Event Reporting program online at: https://www.accessdata.fda.gov/scripts/medwatch/medwatch-online.htm; by regular mail by using FDA postage paid form, which is to be mailed to MedWatch, 5600 Fishers Lane, Rockville, Maryland, 20852-9787. The form can be accessed at: https://www.accessdata.fda.gov/scripts/medwatch/. The FDA can also be reached via Fax toll-free at 1-800-FDA-0178 or by telephone, toll-free, at 1-800-FDA-1088.